COMMUNIQUÉS West-GlobeNewswire

Quantum Electrodynamics and Ibogaine: Enhancing Work Performance
21/04/2024
Ibogaine By David Dardashti claims improved treatment efficacy due to electromagnetic waves MIAMI, April 21, 2024 (GLOBE NEWSWIRE) -- Ibogaine By David Dardashti, a leader in the field of ibogaine therapy, is [...]
Ibogaine By David Dardashti Encourages Patients to Practice Compassion
21/04/2024
Misty Huckabey explains how to Focus on Promoting Self-Love and Compassion MIAMI, April 21, 2024 (GLOBE NEWSWIRE) -- Ibogaine By David Dardashti, an organization that provides ibogaine-assisted addiction treatment, is [...]
Ibogaine By David Dardashti Offers Expanded Treatment Options
21/04/2024
Ibogaine By David Dardashti Enhances Treatment with Holistic Therapy Services MIAMI, April 21, 2024 (GLOBE NEWSWIRE) -- Ibogaine By David Dardashti is proud to announce an expanded treatment program providing greater [...]
Ibogaine By David Dardashti Takes Pride in Participating in Sexual Awareness Month
21/04/2024
Clinic Works to Create New Solutions to Combat Sexual Assault MIAMI, April 21, 2024 (GLOBE NEWSWIRE) -- Ibogaine By David Dardashti is a specialized clinic that focuses on treating addiction, particularly in instances [...]
Ibogaine By David Dardashti Announces New Algorithm For Alcohol Addiction
21/04/2024
Revolutionary Method to Combat Alcoholism and Restore Quality of Life MIAMI, April 21, 2024 (GLOBE NEWSWIRE) -- Ibogaine By David Dardashti, a prominent provider of natural and holistic remedies for substance abuse, has [...]
Ibogaine by David Dardashti Introduces New Algorithm for Methadone Addiction
21/04/2024
Algorithm Varies Slightly from Suboxone and Focuses on Continuously Dosed Ibogaine Treatment MIAMI, April 21, 2024 (GLOBE NEWSWIRE) -- The novel algorithm signifies a notable deviation from Suboxone, a frequently [...]
Ibogaine By David Dardashti Introduces New Algorithm for Depression Treatment
21/04/2024
A Revolutionary Advancement in Depression Treatments MIAMI, April 21, 2024 (GLOBE NEWSWIRE) -- In recent years, there has been a surge in clinical studies exploring the use of Ibogaine in treating depression. David [...]
Remedium Healthcare Products Launches NuVeria Labs' Groundbreaking Sacral Silicone Dressing, Now Available for Purchase on Amazon Prime
20/04/2024
Remedium Healthcare Products announces the launch of NuVeria Labs' Sacral Silicone Dressing on Amazon, setting a new standard in accessible, advanced wound care NORTHBROOK, Ill., April 19, 2024 (GLOBE NEWSWIRE) -- [...]
Vaxxinity Issues Shareholder Letter
20/04/2024
CAPE CANAVERAL, Fla., April 19, 2024 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (“Vaxxinity”, “we”, “us” or the “Company”) (Nasdaq: VAXX), a U.S. company pioneering the development of a new class of medicines, today announced [...]
Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing
19/04/2024
FLORHAM PARK, N.J., April 19, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (NASDAQ: CELU) (the “Company”), a regenerative medicine company developing placental-derived allogeneic cell therapies and advanced biomaterial [...]
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
19/04/2024
SAN CARLOS, Calif., April 19, 2024 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) (“Iovance” or the “Company”), a biotechnology company focused on innovating, developing, and delivering novel [...]
ASLAN Pharmaceuticals Announces Receipt of Nasdaq Notice
19/04/2024
SAN MATEO, Calif. and SINGAPORE, April 19, 2024 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq: ASLN), a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to transform the [...]
StateHouse Provides an Update on Application for Management Cease Trade Order
19/04/2024
SAN DIEGO and TORONTO, April 19, 2024 (GLOBE NEWSWIRE) -- StateHouse Holdings Inc . (“StateHouse” or the “Company”) (CSE: STHZ) (OTCQB: STHZF), a California-focused, vertically integrated cannabis company, today [...]
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
19/04/2024
NOVATO, Calif., April 19, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultrarare [...]
Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Quarterly Report
19/04/2024
CHASKA, Minn., April 19, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (the “Company”) announced today that, on April 15, 2024, the Company received a notification letter (the “Notice”) from the [...]
Hepion Pharmaceuticals Initiates Wind-Down Activities in Phase 2b ‘ASCEND-NASH’ Trial
19/04/2024
EDISON, N.J., April 19, 2024 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company that has been developing a treatment for non-alcoholic steatohepatitis (“NASH”), [...]
Vaxxinity Announces Intention to Voluntarily Delist and Deregister its Class A Common Stock
19/04/2024
CAPE CANAVERAL, Fla., April 19, 2024 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (“Vaxxinity”, “we”, “us” or the “Company”) (Nasdaq: VAXX), a U.S. company pioneering the development of a new class of medicines, today announced [...]
Correction to Company announcement – No. 23 / 2024
19/04/2024
Correction to Company announcement – No. 23 / 2024 Copenhagen, Denmark, April 19, 2024 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the [...]
Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
19/04/2024
REDWOOD CITY, Calif., April 19, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, [...]

Pages